Could inhaling cancer drug be better than swallowing it? new study in smokers aims to find out
NCT ID NCT06897735
First seen Nov 18, 2025 · Last updated May 19, 2026 · Updated 19 times
Summary
This early-phase study compares an inhaled version of the cancer drug afatinib to the standard oral pill in 24 healthy adult smokers. Researchers want to see if the inhaled form delivers the drug more directly to the lungs with fewer side effects. Participants will receive both forms at different times, and the study measures drug levels in blood, urine, and lung fluid. This is a pilot study to gather safety and dosing information, not a treatment trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Central Contact
Auckland, New Zealand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.